Send us a text)
Why do so many digital pathology tools stall before they ever reach patients?
In this USCAP 2025 special sponsored by Muse Microscopy), I talk with Esther Abels, founder of SolarisRTC, regulatory strategist, and the force behind the first FDA-cleared whole slide imaging system.
We break down what startups and established companies must do from day one to succeedbin getting their devices through the FDA. Hint: regulatory strategy isn’t a final step—it’s your starting line.
🧠 What You’ll Learn:
- [00:01:00] Why regulatory planning must start at inception
- [00:03:00] How Esther helped Philips get the first scanner FDA cleared
- [00:05:00] Clinical study design, documentation, and risk strategy
- [00:08:00] Timeline expectations for clearance and review
- [00:10:00] The role of consultants vs. internal regulatory teams
- [00:13:00] Using meta-analysis, synthetic data, and publications
- [00:15:00] How the DPA is driving system decoupling & AI regulatory clarity
🎧 Tune in to learn how to build compliance into innovation—from tissue imaging to AI-powered diagnostics.
#DigitalPathology #RegulatoryStrategy #FDAApproval #ClinicalInnovation #PathologyTools #MUSEmiscroscopy #sponsored #USCAP2025
Support the show)
Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!)
